Prof. Hans-Christoph Diener MD PhD will lead clinical studies in migraine for Curelator Inc.

Hans-Christoph Diener MD PhD, Professor of Neurology, Chairman of the Department of Neurology and Director of the Essen Headache Centre at the University of Duisburg-Essen in Germany.

Prof. Diener’s work helped establish migraine as a neurological disorder when many thought it was just a psychosomatic disease.

Hans-Christoph Diener MD PhD from Essen, Germany has joined the clinical advisory board of Curelator Inc. to design and lead several multi-center global studies in headache disorders. These studies will use Curelator Headache, a digital migraine application, to measure the individual (N=1) impact of treatment interventions for each patient participating in the studies.

Alec Mian, the CEO and Founder of Curelator explains: “Prof. Diener’s work helped establish migraine as a neurological disorder when many thought it was just a psychosomatic disease. His subsequent contributions to the field include identifying the factors that lead to drug-induced headache and co-authoring the guidelines that set a common standard for migraine drug trials. We are delighted to have him join our team to design the first global real world clinical studies that employ a patient-centric digital platform to measure outcomes of different treatment strategies.” [1-6]

Dr. Diener adds, “The collection of real world clinical data combined with n=1 analytics to measure individual outcomes and develop individual patient profiles is becoming an increasingly important paradigm in medicine. This is the promise of Curelator.”

Prof. Diener is currently Professor of Neurology, Chairman of the Department of Neurology and Director of the Essen Headache Centre at the University of Duisburg-Essen in Germany. He was formerly President of the German Neurological Society, President of the European Headache Federation (EHF), and the International Headache Society (IHS) and chairs the German Headache Consortium and the German Stroke Data Bank.

Prof. Diener has authored or co-authored 900 articles in peer reviewed journals (181 as first author, 19 in the NEJM), 324 invited reviews, and 343 book chapters, served as the editor or author of 81 books; and has been the Principal Investigator in more than 30 trials on the acute treatment…

Read the full article from the Source…

Leave a Reply

Your email address will not be published. Required fields are marked *